Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:28 pm Purchase | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,384,646 4.200% | 43,943![]() (+3.28%) | Filing History |
| 2025-11-14 08:18 am Sale | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | Deep Track Capital, LP | 2,279,892 6.990% | -504,756![]() (-18.13%) | Filing History |
| 2025-10-17 6:40 pm Purchase | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | BlackRock Inc. BLK | 2,150,203 6.600% | 435,865![]() (+25.42%) | Filing History |
| 2025-10-16 7:35 pm Purchase | 2025-10-08 | 13G | Jade Biosciences, Inc. JBIO | RA CAPITAL MANAGEMENT L.P. | 3,214,969 7.000% | 1,890,015![]() (+142.65%) | Filing History |
| 2025-10-08 4:15 pm Purchase | 2025-10-06 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 10,353,875 19.990% | 3,104,519![]() (+42.82%) | Filing History |
| 2025-08-14 1:46 pm Sale | 2025-06-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,340,703 4.200% | -431,413![]() (-24.34%) | Filing History |
| 2025-07-29 1:46 pm Purchase | 2025-06-30 | 13G | Jade Biosciences, Inc. JBIO | VANGUARD GROUP INC | 1,807,582 5.600% | 1,807,582![]() (New Position) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | Jade Biosciences, Inc. JBIO | BlackRock Inc. BLK | 1,714,338 5.300% | 1,714,338![]() (New Position) | Filing History |
| 2025-06-20 4:23 pm Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | Deep Track Capital, LP | 2,784,648 8.640% | 2,784,648![]() (New Position) | Filing History |
| 2025-06-06 10:03 am Purchase | 2025-05-30 | 13G | Jade Biosciences, Inc. JBIO | FMR LLC | 4,735,951 14.700% | 4,735,951![]() (New Position) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | TCG Crossover GP I, LLC | 64,023 0.200% | 64,023![]() (New Position) | Filing History |
| 2025-05-05 4:26 pm Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | Venrock Healthcare Capital Partners III, L.P. | 3,220,369 9.900% | 3,220,369![]() (New Position) | Filing History |
| 2025-05-05 09:43 am Purchase | 2025-04-28 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,772,116 5.500% | 1,772,116![]() (New Position) | Filing History |
| 2025-05-01 6:31 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 7,249,356 19.990% | 7,249,356![]() (New Position) | Filing History |
| 2025-04-30 4:51 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | RA CAPITAL MANAGEMENT L.P. | 1,324,954 4.100% | 1,324,954![]() (New Position) | Filing History |
| 2025-04-30 4:29 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | Atlas Venture Fund XII, L.P. | 51,406 0.200% | 51,406![]() (New Position) | Filing History |
| 2024-11-14 4:21 pm Sale | 2024-09-30 | 13G | Aerovate Therapeutics, Inc. AVTE | BAKER BROS. ADVISORS LP | 17,970 2.200% | -30,045![]() (-62.57%) | Filing History |
| 2024-06-20 6:00 pm Purchase | 2024-06-17 | 13D | Aerovate Therapeutics, Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 264,060 32.000% | 26,517![]() (+11.16%) | Filing History |
| 2024-04-30 4:16 pm Purchase | 2024-04-26 | 13D | Aerovate Therapeutics, Inc. AVTE | RA CAPITAL MANAGEMENT L.P. | 237,542 28.900% | 595![]() (+0.25%) | Filing History |
| 2024-02-20 7:09 pm Purchase | 2023-06-21 | 13D | Aerovate Therapeutics, Inc. AVTE | Sofinnova Venture Partners X L.P. | 108,780 13.800% | 677![]() (+0.63%) | Filing History |

